Insider Transactions in Q4 2024 at Supernus Pharmaceuticals, Inc. (SUPN)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 11
2024
|
Charles W Newhall Iii Director |
SELL
Open market or private sale
|
Direct |
10,700
-7.59%
|
$385,200
$36.24 P/Share
|
|
Nov 11
2024
|
Charles W Newhall Iii Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+12.42%
|
$180,000
$9.13 P/Share
|
|
Nov 08
2024
|
Frederick M. Hudson Director |
SELL
Open market or private sale
|
Direct |
8,722
-23.5%
|
$313,992
$36.28 P/Share
|
|
Nov 08
2024
|
Jack A. Khattar President, CEO |
SELL
Open market or private sale
|
Direct |
125,000
-11.89%
|
$4,500,000
$36.29 P/Share
|
|
Nov 08
2024
|
Jack A. Khattar President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
125,000
+10.63%
|
$1,125,000
$9.13 P/Share
|
|
Nov 08
2024
|
Georges Gemayel Director |
SELL
Open market or private sale
|
Direct |
10,787
-44.76%
|
$388,332
$36.3 P/Share
|
|
Nov 08
2024
|
Georges Gemayel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,787
+30.92%
|
$118,657
$11.46 P/Share
|
|
Nov 07
2024
|
Frank Mottola SVP, Quality, GMP, Ops, IT |
SELL
Open market or private sale
|
Direct |
15,000
-64.66%
|
$540,000
$36.98 P/Share
|
|
Nov 07
2024
|
Frank Mottola SVP, Quality, GMP, Ops, IT |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+39.27%
|
$135,000
$9.13 P/Share
|
|
Nov 07
2024
|
Jack A. Khattar President, CEO |
SELL
Open market or private sale
|
Direct |
125,000
-11.89%
|
$4,500,000
$36.68 P/Share
|
|
Nov 07
2024
|
Jack A. Khattar President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
125,000
+10.63%
|
$1,125,000
$9.13 P/Share
|
|
Nov 07
2024
|
Georges Gemayel Director |
SELL
Open market or private sale
|
Direct |
14,213
-51.63%
|
$511,668
$36.62 P/Share
|
|
Nov 07
2024
|
Georges Gemayel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,213
+34.05%
|
$156,343
$11.46 P/Share
|